{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:05:28Z","timestamp":1780344328449,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1053\/ajkd.2002.34510","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"315-322","source":"Crossref","is-referenced-by-count":54,"title":["Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular risk"],"prefix":"10.1053","volume":"40","author":[{"given":"Atul","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer S.","family":"Kabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery M.","family":"Rimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.John","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Taatjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton E.","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2002.34510_bib1","series-title":"USRDS 1997 Annual Data Report","author":"Renal Data System","year":"1997"},{"issue":"suppl 3","key":"10.1053\/ajkd.2002.34510_bib2","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.34510_bib3","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/01.CIR.102.24.2966","article-title":"Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?","volume":"102","author":"Rubenstein","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.34510_bib4","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1161\/01.CIR.102.24.2973","article-title":"Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group","volume":"102","author":"Liu","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.34510_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.34510_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.84.2.613","article-title":"Blood platelet count and function are related to total and cardiovascular death in apparently healthy men","volume":"84","author":"Thaulow","year":"1991","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.34510_bib7","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","article-title":"Platelet hyperreactivity and prognosis in survivors of myocardial infarction","volume":"322","author":"Trip","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2002.34510_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9149(94)90004-3","article-title":"Platelet aggregation, coronary artery disease progression and future coronary events","volume":"73","author":"Lam","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1053\/ajkd.2002.34510_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0272-6386(12)80429-X","article-title":"Reversible activation defect of the glycoprotein IIb-IIIa complex in patients with uremia","volume":"22","author":"Benigni","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.34510_bib10","first-page":"79","article-title":"Platelet activation during hemodialysis measured through exposure of P-selectin: Analysis by flow cytometric and ultrastructural techniques","volume":"124","author":"Reverter","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1053\/ajkd.2002.34510_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0002-9343(87)90749-2","article-title":"Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis","volume":"83","author":"Schmitt","year":"1987","journal-title":"Am J Med"},{"key":"10.1053\/ajkd.2002.34510_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ki.1997.117","article-title":"Increased reticulated platelets in dialysis patients","volume":"51","author":"Himmelfarb","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2002.34510_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0272-6386(95)90123-X","article-title":"Defective platelet aggregation in uremia is transiently worsened by hemodialysis","volume":"25","author":"Sreedhara","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2002.34510_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF00180515","article-title":"Changes in platelet membrane glycoproteins and platelet-leucocyte interaction during hemodialysis","volume":"72","author":"Gawaz","year":"1994","journal-title":"Clin Invest"},{"key":"10.1053\/ajkd.2002.34510_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1681\/ASN.V85799","article-title":"Studies on platelet membrane glycoproteins and platelet function during hemodialysis","volume":"8","author":"Sloand","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2002.34510_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9343(85)90051-8","article-title":"Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis","volume":"79","author":"Di Minno","year":"1985","journal-title":"Am J Med"},{"key":"10.1053\/ajkd.2002.34510_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0037-1615088","article-title":"European working group on clinical cell analysis: Consensus protocol for the flow cytometric characterization of platelet function","volume":"79","author":"Schmitz","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/ajkd.2002.34510_bib18","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/01.CIR.96.9.2877","article-title":"Differential effects of anticoagulants on the activation of platelets ex vivo","volume":"96","author":"Schneider","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.34510_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0049-3848(99)00019-5","article-title":"Differences between activation thresholds for platelet P-selectin and glycoprotein IIb-IIIa expression and their clinical implications","volume":"95","author":"Holmes","year":"1999","journal-title":"Thromb Res"},{"key":"10.1053\/ajkd.2002.34510_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.CIR.104.2.181","article-title":"Platelet reactivity characterized prospectively: A determinant of outcome 90 days after percutaneous coronary intervention","volume":"104","author":"Kabbani","year":"2001","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2002.34510_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(99)00235-0","article-title":"Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects","volume":"84","author":"Holmes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1053\/ajkd.2002.34510_bib22","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood.V88.9.3432.bloodjournal8893432","article-title":"Blood clotting in minimally altered whole blood","volume":"88","author":"Rand","year":"1996","journal-title":"Blood"},{"key":"10.1053\/ajkd.2002.34510_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0735-1097(98)00515-4","article-title":"Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: A potential contributor to cardiovascular risk","volume":"33","author":"Schneider","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/ajkd.2002.34510_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1996.445980.x","article-title":"Optimally functional fluorescein isothiocyanate-labelled fibrinogen for quantification of binding to activated platelets and platelet aggregation","volume":"93","author":"Xia","year":"1996","journal-title":"Br J Hematol"},{"key":"10.1053\/ajkd.2002.34510_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.ATV.17.4.646","article-title":"Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis","volume":"17","author":"Holme","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/ajkd.2002.34510_bib26","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1021\/bi00036a039","article-title":"Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: A study using Ca2+-ATPase inhibitors","volume":"34","author":"Dachary-Prigent","year":"1995","journal-title":"Biochemistry"},{"key":"10.1053\/ajkd.2002.34510_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1525-1594.1997.tb00371.x","article-title":"In vivo evaluation of platelet activation by different cellulosic membranes","volume":"21","author":"Cases","year":"1997","journal-title":"Artif Organs"},{"key":"10.1053\/ajkd.2002.34510_bib28","first-page":"652","article-title":"Cardiac disease in dialysis patients","author":"Rostand","year":"1995"},{"key":"10.1053\/ajkd.2002.34510_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0002-9343(70)80026-2","article-title":"The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation in patients with renal failure","volume":"44","author":"Rabiner","year":"1970","journal-title":"Am J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T05:01:05Z","timestamp":1622091665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638602000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0272638602000458"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2002.34510","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}